Marker Therapeutics Inc. (MRKR) NASDAQ
$4.43 - (-)
Market Cap: $39.40M
As of 04/23/24 12:00 AM EDT. Market closed.
Marker Therapeutics Inc. (MRKR)
NASDAQ
$4.43
- (-)
Market Cap: $39.40M
As of 04/23/24 12:00 AM EDT. Market closed.
Add to Portfolio
tapimmune is developing immunotherapies for a variety of cancers designed to target both tumors and metastatic disease. the company’s next-generation technology has been engineered to overcome the deficiencies of earlier cancer vaccine approaches and has the potential to be a powerful standalone therapy or part of a leading combination regimen by complementing other approved or ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Peter Hoang
Full Time Employees
3
CEO Compensation (Base)
$362,500
CEO Compensation (Total)
$13.01M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Peter Hoang
Full Time Employees
3
CEO Compensation (Base)
$362,500
CEO Compensation (Total)
$13.01M
Address
5 W Forsyth St Ste 200, Florida, Jacksonville, 32202-3676.
PRICE CHART FOR MARKER THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$4.43
Days Range
$4.15 - $4.48
52 week range
$0.76 - $9.68
Volume
9,980
Avg. Volume (30 days)
21,549
Market Cap
$39.40M
Dividend Yield
-
P/E
-
Shares Outstanding
8,902,897
Open
-
Previous Close
$4.43
Days Range
$4.15 - $4.48
52 week range
$0.76 - $9.68
Volume
9,980
Avg. Volume (30 days)
21,549
Market Cap
$39.40M
Dividend Yield
-
P/E
-
Shares Outstanding
8,902,897
FINANCIAL STATEMENTS FOR MARKER THERAPEUTICS INC
LOADING...
INSIDER TRANSACTIONS FOR MARKER THERAPEUTICS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Eansor Norman David | Director | Mar 16, 2021 | Buy | $17.50 | 14,285 | 249,988 | 16,713 | Jun 08, 2023, 09:35 PM |
Hoang Peter L. | President and CEO | Mar 24, 2022 | Option Exercise | $0.48 | 48,376 | 23,453 | 483,286 | Mar 28, 2022, 09:06 PM |
Vera Juan | Chief Scientific Officer & COO | Mar 24, 2022 | Option Exercise | $0.48 | 33,465 | 16,224 | 2,671,845 | Mar 28, 2022, 09:04 PM |
Kim Anthony H. | Chief Financial Officer | Mar 24, 2022 | Option Exercise | $0.48 | 36,076 | 17,490 | 114,436 | Mar 28, 2022, 09:03 PM |
Walker Paul Edward | 10% Owner | Mar 16, 2021 | Buy | $1.75 | 5,714,285 | 9,999,999 | 10,714,285 | Mar 18, 2021, 05:18 PM |
Sonsini Peter W. | 10% Owner | Mar 16, 2021 | Buy | $1.75 | 5,714,285 | 9,999,999 | 10,714,285 | Mar 18, 2021, 05:17 PM |
SANDELL SCOTT D | 10% Owner | Mar 16, 2021 | Buy | $1.75 | 5,714,285 | 9,999,999 | 10,714,285 | Mar 18, 2021, 05:17 PM |
MAKOWER JOSHUA | 10% Owner | Mar 16, 2021 | Buy | $1.75 | 5,714,285 | 9,999,999 | 10,714,285 | Mar 18, 2021, 05:16 PM |
Makhzoumi Mohamad | 10% Owner | Mar 16, 2021 | Buy | $1.75 | 5,714,285 | 9,999,999 | 10,714,285 | Mar 18, 2021, 05:15 PM |
Florence Anthony A. Jr. | 10% Owner | Mar 16, 2021 | Buy | $1.75 | 5,714,285 | 9,999,999 | 10,714,285 | Mar 18, 2021, 05:14 PM |
Chang Carmen | 10% Owner | Mar 16, 2021 | Buy | $1.75 | 5,714,285 | 9,999,999 | 10,714,285 | Mar 18, 2021, 05:12 PM |
Behbahani Ali | 10% Owner | Mar 16, 2021 | Buy | $1.75 | 5,714,285 | 9,999,999 | 10,714,285 | Mar 18, 2021, 05:11 PM |
BASKETT FOREST | 10% Owner | Mar 16, 2021 | Buy | $1.75 | 5,714,285 | 9,999,999 | 10,714,285 | Mar 18, 2021, 05:09 PM |
New Enterprise Associates 16, L.P. | 10% Owner | Mar 16, 2021 | Buy | $1.75 | 5,714,285 | 9,999,999 | 10,714,285 | Mar 18, 2021, 05:08 PM |
Wilson John Robert | Director | Mar 16, 2021 | Buy | $1.75 | 1,714,285 | 2,999,999 | 7,799,350 | Mar 18, 2021, 04:39 PM |
Vera Juan | Chief Development Officer | Mar 16, 2021 | Buy | $1.75 | 571,428 | 999,999 | 2,564,487 | Mar 18, 2021, 04:38 PM |
Hoang Peter L. | President and CEO | Mar 16, 2021 | Buy | $1.75 | 142,857 | 250,000 | 332,568 | Mar 18, 2021, 04:36 PM |
ELMS STEVE | Director | Mar 16, 2021 | Buy | $1.75 | 1,142,857 | 2,000,000 | 3,142,857 | Mar 18, 2021, 04:35 PM |
Eastern Capital LTD | 10% Owner | Feb 18, 2020 | Option Exercise | $1.20 | 416,667 | 500,000 | 4,050,001 | Feb 20, 2020, 04:50 PM |
Hoang Peter L. | President and CEO | Aug 14, 2019 | Buy | $4.62 | 10,000 | 46,200 | 189,711 | Aug 15, 2019, 04:33 PM |
Eastern Capital LTD | 10% Owner | May 14, 2018 | Buy | $2.40 | 1,300,000 | 3,120,000 | 5,300,002 | May 16, 2018, 05:28 PM |
WILSON GLYNN | Director | Sep 22, 2017 | Option Exercise | $3.18 | 100,000 | 318,000 | 185,567 | Sep 26, 2017, 04:05 PM |
WILSON GLYNN | Director | Sep 22, 2017 | Option Exercise | $3.18 | 27,350 | 86,973 | 158,217 | Sep 26, 2017, 04:05 PM |
Hoang Peter L. | CEO and President | Sep 22, 2017 | Option Exercise | $3.18 | 250,000 | 795,000 | 250,000 | Sep 25, 2017, 03:11 PM |
Hoang Peter L. | CEO and President | Sep 22, 2017 | Option Exercise | $3.18 | 70,289 | 223,519 | 179,711 | Sep 25, 2017, 03:11 PM |
BONFIGLIO JOHN N | President and COO | Dec 12, 2016 | Option Exercise | $1.74 | 10,417 | 18,126 | 31,251 | Dec 14, 2016, 04:31 PM |
Eastern Capital LTD | 10% Owner | Aug 10, 2016 | Option Exercise | $0.50 | 5,000,000 | 2,500,000 | 25,000,000 | Aug 12, 2016, 04:40 PM |
WILSON GLYNN | Director | Nov 12, 2015 | Option Exercise | $0.61 | 315,000 | 190,575 | 960,457 | Nov 16, 2015, 05:06 PM |
WILSON GLYNN | Director | Nov 12, 2015 | Option Exercise | $0.61 | 86,782 | 52,503 | 873,675 | Nov 16, 2015, 05:06 PM |
Grisewood Sherry | Director | Feb 26, 2014 | Option Exercise | $0.80 | 28,125 | 22,500 | 28,330 | Nov 13, 2015, 05:28 PM |
Reddish Mark | Director | Feb 26, 2014 | Option Exercise | $0.80 | 225,000 | 180,000 | 226,667 | Nov 13, 2015, 05:04 PM |
WILSON GLYNN | Director | Dec 02, 2014 | Option Exercise | $1.00 | 120,000 | 120,000 | 645,457 | Nov 13, 2015, 04:58 PM |
WILSON GLYNN | Director | Feb 26, 2014 | Option Exercise | $0.80 | 513,319 | 410,655 | 525,457 | Nov 13, 2015, 04:58 PM |
Eastern Capital LTD | 10% Owner | Sep 09, 2015 | Option Exercise | $0.20 | 10,000,000 | 2,000,000 | 20,000,000 | Sep 11, 2015, 04:16 PM |
Eastern Capital LTD | 10% Owner | Jun 16, 2015 | Option Exercise | $0.50 | 5,000,000 | 2,500,000 | 10,000,000 | Jun 18, 2015, 11:33 AM |
WILSON GLYNN | CEO | Feb 17, 2012 | Option Exercise | $0.15 | 166,667 | 25,000 | 1,213,726 | Apr 24, 2012, 12:46 PM |
CORIN DENIS | President | Feb 17, 2012 | Option Exercise | $0.15 | 166,667 | 25,000 | 2,394,535 | Apr 20, 2012, 05:55 PM |
WILSON GLYNN | Chairman and CEO | Mar 23, 2011 | Option Exercise | $0.17 | 147,059 | 25,000 | 1,047,059 | Apr 05, 2011, 05:02 PM |
CORIN DENIS | President and CFO | Mar 23, 2011 | Option Exercise | $0.17 | 294,118 | 50,000 | 2,227,868 | Apr 05, 2011, 04:45 PM |
CORIN DENIS | President and CFO | Mar 23, 2011 | Sale | $0.12 | 160,000 | 19,200 | 135,300 | Apr 05, 2011, 04:45 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Eansor Norman David | Director | 03/16/2021 | 249,988 |
Hoang Peter L. | President and CEO | 03/24/2022 | 23,453 |
Vera Juan | Chief Scientific Officer & COO | 03/24/2022 | 16,224 |
Kim Anthony H. | Chief Financial Officer | 03/24/2022 | 17,490 |
Walker Paul Edward | 10% Owner | 03/16/2021 | 9,999,999 |
Sonsini Peter W. | 10% Owner | 03/16/2021 | 9,999,999 |
SANDELL SCOTT D | 10% Owner | 03/16/2021 | 9,999,999 |
MAKOWER JOSHUA | 10% Owner | 03/16/2021 | 9,999,999 |
Makhzoumi Mohamad | 10% Owner | 03/16/2021 | 9,999,999 |
Florence Anthony A. Jr. | 10% Owner | 03/16/2021 | 9,999,999 |
Chang Carmen | 10% Owner | 03/16/2021 | 9,999,999 |
Behbahani Ali | 10% Owner | 03/16/2021 | 9,999,999 |
BASKETT FOREST | 10% Owner | 03/16/2021 | 9,999,999 |
New Enterprise Associates 16, L.P. | 10% Owner | 03/16/2021 | 9,999,999 |
Wilson John Robert | Director | 03/16/2021 | 2,999,999 |
Vera Juan | Chief Development Officer | 03/16/2021 | 999,999 |
Hoang Peter L. | President and CEO | 03/16/2021 | 250,000 |
ELMS STEVE | Director | 03/16/2021 | 2,000,000 |
Eastern Capital LTD | 10% Owner | 02/18/2020 | 500,000 |
Hoang Peter L. | President and CEO | 08/14/2019 | 46,200 |
Eastern Capital LTD | 10% Owner | 05/14/2018 | 3,120,000 |
WILSON GLYNN | Director | 09/22/2017 | 318,000 |
WILSON GLYNN | Director | 09/22/2017 | 86,973 |
Hoang Peter L. | CEO and President | 09/22/2017 | 795,000 |
Hoang Peter L. | CEO and President | 09/22/2017 | 223,519 |
BONFIGLIO JOHN N | President and COO | 12/12/2016 | 18,126 |
Eastern Capital LTD | 10% Owner | 08/10/2016 | 2,500,000 |
WILSON GLYNN | Director | 11/12/2015 | 190,575 |
WILSON GLYNN | Director | 11/12/2015 | 52,503 |
Grisewood Sherry | Director | 02/26/2014 | 22,500 |
Reddish Mark | Director | 02/26/2014 | 180,000 |
WILSON GLYNN | Director | 12/02/2014 | 120,000 |
WILSON GLYNN | Director | 02/26/2014 | 410,655 |
Eastern Capital LTD | 10% Owner | 09/09/2015 | 2,000,000 |
Eastern Capital LTD | 10% Owner | 06/16/2015 | 2,500,000 |
WILSON GLYNN | CEO | 02/17/2012 | 25,000 |
CORIN DENIS | President | 02/17/2012 | 25,000 |
WILSON GLYNN | Chairman and CEO | 03/23/2011 | 25,000 |
CORIN DENIS | President and CFO | 03/23/2011 | 50,000 |
CORIN DENIS | President and CFO | 03/23/2011 | 19,200 |
Load More Insider Transactions
FUNDS WITH A POSITION IN MARKER THERAPEUTICS INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
GEODE CAPITAL MANAGEMENT, LLC | 60,047 | 0.00003% | No change | Other |
RENAISSANCE TECHNOLOGIES LLC | 37,550 | 0.00032% | -6.71% | Other |
BLACKROCK INC. | 1,364 | 0% | No change | Other |
CHANGE IN SHARES OUTSTANDING FOR MARKER THERAPEUTICS INC
STOCK BUYBACKS FOR MARKER THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
-1.04%
1Q
06/30/2023
-0.74%
2Q
03/31/2023
0.15%
3Q
12/31/2022
4.30%
4Q
09/30/2022
4.47%
5Q
06/30/2022
4.48%
6Q
03/31/2022
5.09%
7Q
12/31/2021
5.04%
8Q
09/30/2021
5.13%
9Q
06/30/2021
5.19%
10Q
03/31/2021
54.67%
11Q
12/31/2020
79.60%
12Q
09/30/2020
86.36%
13Q
06/30/2020
87.53%
14Q
03/31/2020
89.52%
15Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR MARKER THERAPEUTICS INC
LOADING...